Body Fat Distribution and the Risk of Incident Metabolic Syndrome: A Longitudinal Cohort Study

The effect of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) area on metabolic syndrome (MS) has been debated. We aimed to evaluate the effects of VAT and SAT on the incidence of MS and its components in a large and apparently healthy Asian population. We performed a longitudina...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 7; no. 1; pp. 10955 - 8
Main Authors Kwon, Hyuktae, Kim, Donghee, Kim, Joo Sung
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 08.09.2017
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The effect of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) area on metabolic syndrome (MS) has been debated. We aimed to evaluate the effects of VAT and SAT on the incidence of MS and its components in a large and apparently healthy Asian population. We performed a longitudinal cohort study of 1,964 subjects who received health screenings over a 5-year follow-up period; 317 incidents of MS (16.1%) were observed during a median follow-up of 4.5 years. The VAT area was significantly associated with a higher incidence of MS; the adjusted HR for incident MS per 1 SD of VAT was 1.50 (95% CI 1.29–1.74), and the adjusted HR of the 5 th VAT quintile compared with the 1 st quintile was 3.73 (95% CI 2.22–6.28). However, the SAT area was not associated with incident MS. Although the VAT area was longitudinally associated with the incidence of each component of MS, the SAT area was inversely associated with the risk of high blood pressure, fasting blood sugar, and triglycerides, with marginal significance. In conclusion, the VAT area is longitudinally associated with an increased risk of incident MS, while SAT may have a protective effect against the incidence of individual MS components.
AbstractList The effect of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) area on metabolic syndrome (MS) has been debated. We aimed to evaluate the effects of VAT and SAT on the incidence of MS and its components in a large and apparently healthy Asian population. We performed a longitudinal cohort study of 1,964 subjects who received health screenings over a 5-year follow-up period; 317 incidents of MS (16.1%) were observed during a median follow-up of 4.5 years. The VAT area was significantly associated with a higher incidence of MS; the adjusted HR for incident MS per 1 SD of VAT was 1.50 (95% CI 1.29-1.74), and the adjusted HR of the 5th VAT quintile compared with the 1st quintile was 3.73 (95% CI 2.22-6.28). However, the SAT area was not associated with incident MS. Although the VAT area was longitudinally associated with the incidence of each component of MS, the SAT area was inversely associated with the risk of high blood pressure, fasting blood sugar, and triglycerides, with marginal significance. In conclusion, the VAT area is longitudinally associated with an increased risk of incident MS, while SAT may have a protective effect against the incidence of individual MS components.The effect of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) area on metabolic syndrome (MS) has been debated. We aimed to evaluate the effects of VAT and SAT on the incidence of MS and its components in a large and apparently healthy Asian population. We performed a longitudinal cohort study of 1,964 subjects who received health screenings over a 5-year follow-up period; 317 incidents of MS (16.1%) were observed during a median follow-up of 4.5 years. The VAT area was significantly associated with a higher incidence of MS; the adjusted HR for incident MS per 1 SD of VAT was 1.50 (95% CI 1.29-1.74), and the adjusted HR of the 5th VAT quintile compared with the 1st quintile was 3.73 (95% CI 2.22-6.28). However, the SAT area was not associated with incident MS. Although the VAT area was longitudinally associated with the incidence of each component of MS, the SAT area was inversely associated with the risk of high blood pressure, fasting blood sugar, and triglycerides, with marginal significance. In conclusion, the VAT area is longitudinally associated with an increased risk of incident MS, while SAT may have a protective effect against the incidence of individual MS components.
The effect of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) area on metabolic syndrome (MS) has been debated. We aimed to evaluate the effects of VAT and SAT on the incidence of MS and its components in a large and apparently healthy Asian population. We performed a longitudinal cohort study of 1,964 subjects who received health screenings over a 5-year follow-up period; 317 incidents of MS (16.1%) were observed during a median follow-up of 4.5 years. The VAT area was significantly associated with a higher incidence of MS; the adjusted HR for incident MS per 1 SD of VAT was 1.50 (95% CI 1.29–1.74), and the adjusted HR of the 5 th VAT quintile compared with the 1 st quintile was 3.73 (95% CI 2.22–6.28). However, the SAT area was not associated with incident MS. Although the VAT area was longitudinally associated with the incidence of each component of MS, the SAT area was inversely associated with the risk of high blood pressure, fasting blood sugar, and triglycerides, with marginal significance. In conclusion, the VAT area is longitudinally associated with an increased risk of incident MS, while SAT may have a protective effect against the incidence of individual MS components.
The effect of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) area on metabolic syndrome (MS) has been debated. We aimed to evaluate the effects of VAT and SAT on the incidence of MS and its components in a large and apparently healthy Asian population. We performed a longitudinal cohort study of 1,964 subjects who received health screenings over a 5-year follow-up period; 317 incidents of MS (16.1%) were observed during a median follow-up of 4.5 years. The VAT area was significantly associated with a higher incidence of MS; the adjusted HR for incident MS per 1 SD of VAT was 1.50 (95% CI 1.29–1.74), and the adjusted HR of the 5th VAT quintile compared with the 1st quintile was 3.73 (95% CI 2.22–6.28). However, the SAT area was not associated with incident MS. Although the VAT area was longitudinally associated with the incidence of each component of MS, the SAT area was inversely associated with the risk of high blood pressure, fasting blood sugar, and triglycerides, with marginal significance. In conclusion, the VAT area is longitudinally associated with an increased risk of incident MS, while SAT may have a protective effect against the incidence of individual MS components.
The effect of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) area on metabolic syndrome (MS) has been debated. We aimed to evaluate the effects of VAT and SAT on the incidence of MS and its components in a large and apparently healthy Asian population. We performed a longitudinal cohort study of 1,964 subjects who received health screenings over a 5-year follow-up period; 317 incidents of MS (16.1%) were observed during a median follow-up of 4.5 years. The VAT area was significantly associated with a higher incidence of MS; the adjusted HR for incident MS per 1 SD of VAT was 1.50 (95% CI 1.29-1.74), and the adjusted HR of the 5 VAT quintile compared with the 1 quintile was 3.73 (95% CI 2.22-6.28). However, the SAT area was not associated with incident MS. Although the VAT area was longitudinally associated with the incidence of each component of MS, the SAT area was inversely associated with the risk of high blood pressure, fasting blood sugar, and triglycerides, with marginal significance. In conclusion, the VAT area is longitudinally associated with an increased risk of incident MS, while SAT may have a protective effect against the incidence of individual MS components.
ArticleNumber 10955
Author Kim, Joo Sung
Kwon, Hyuktae
Kim, Donghee
Author_xml – sequence: 1
  givenname: Hyuktae
  surname: Kwon
  fullname: Kwon, Hyuktae
  organization: Department of Family Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Department of Family Medicine, Seoul National University Hospital & College of Medicine
– sequence: 2
  givenname: Donghee
  orcidid: 0000-0003-1919-6800
  surname: Kim
  fullname: Kim, Donghee
  email: messmd@chol.com
  organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford
– sequence: 3
  givenname: Joo Sung
  surname: Kim
  fullname: Kim, Joo Sung
  organization: Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28887474$$D View this record in MEDLINE/PubMed
BookMark eNp9kV9vFCEUxYlpY2vtF_DBkPjiy1j-LowPJnVrtck2JlZfJQwwu9RZaIFpMt9e1q3NtonyAoTfufdczguwF2JwALzC6B1GVJ5khnkrG4RFg1pBaDM9A4cEMd4QSsjezvkAHOd8jeripGW4fQ4OiJRSMMEOwc-P0U7wXBd45nNJvhuLjwHqYGFZOfjN518w9vAiGG9dKPDSFd3FwRt4NQWb4tq9h6dwEcPSl9H6oAc4j6uYCryq9-kl2O_1kN3x_X4Efpx_-j7_0iy-fr6Yny4aU12URhiGkRZmRqyhupo2unMd6duZxbKfMeMMMr1ljlvBeEeInnUGC9Yi3UpKO3oEPmzr3ozd2llTrSY9qJvk1zpNKmqvHr8Ev1LLeKc4bzHBshZ4e18gxdvR5aLWPhs3DDq4OGaFWyo4RQLzir55gl7HMdXJNxSnG0OYVOr1rqMHK3-_vgJkC5gUc06uf0AwUpuI1TZiVSNWfyJWUxXJJyLji95EVqfyw_-ldCvNtU9YurRj-9-q33EovBE
CitedBy_id crossref_primary_10_1016_j_ejrad_2021_109943
crossref_primary_10_3390_tomography9030085
crossref_primary_10_1016_j_taap_2023_116428
crossref_primary_10_3390_nu14061183
crossref_primary_10_1371_journal_pone_0214994
crossref_primary_10_1016_j_obmed_2019_100150
crossref_primary_10_3390_ijms19051404
crossref_primary_10_1016_j_envpol_2024_123959
crossref_primary_10_1186_s41043_024_00592_6
crossref_primary_10_3390_ijms222111703
crossref_primary_10_3390_cancers13205067
crossref_primary_10_1016_j_dsx_2022_102418
crossref_primary_10_1016_j_semcancer_2023_03_008
crossref_primary_10_1038_s41387_019_0073_1
crossref_primary_10_1016_j_lfs_2022_121149
crossref_primary_10_1111_eve_13894
crossref_primary_10_3390_obesities3030019
crossref_primary_10_5435_JAAOS_D_20_00596
crossref_primary_10_3389_fnut_2024_1517186
crossref_primary_10_3389_fgene_2020_00967
crossref_primary_10_1152_ajpendo_00516_2019
crossref_primary_10_1097_QAD_0000000000003965
crossref_primary_10_1186_s12986_022_00651_x
crossref_primary_10_1371_journal_pone_0259952
crossref_primary_10_1016_j_orcp_2021_06_011
crossref_primary_10_1186_s40001_023_01343_9
crossref_primary_10_4196_kjpp_2021_25_4_355
crossref_primary_10_3389_fmed_2021_751277
crossref_primary_10_3390_jpm11070663
crossref_primary_10_1111_cts_70062
crossref_primary_10_1136_bmjdrc_2019_000824
crossref_primary_10_1038_s41598_019_50606_1
crossref_primary_10_1007_s00394_020_02361_7
crossref_primary_10_1155_2019_9539846
crossref_primary_10_3390_biomedicines13030561
crossref_primary_10_4082_kjfm_18_0122
crossref_primary_10_1210_jendso_bvad057
crossref_primary_10_1007_s41999_024_01047_1
crossref_primary_10_1017_S1368980019004828
crossref_primary_10_3390_cells11213361
crossref_primary_10_1002_bit_27757
crossref_primary_10_5937_fizkul74_32145
crossref_primary_10_1556_1647_2021_00022
crossref_primary_10_1038_s41598_021_04402_5
crossref_primary_10_1111_obr_13327
crossref_primary_10_1016_j_jand_2023_01_006
crossref_primary_10_1080_07435800_2020_1721528
crossref_primary_10_3390_jcm10040745
crossref_primary_10_1016_j_hnm_2023_200206
crossref_primary_10_1080_17476348_2018_1506331
crossref_primary_10_3390_molecules26071907
crossref_primary_10_1002_ajhb_24141
crossref_primary_10_1049_enb2_12015
crossref_primary_10_2147_DMSO_S428844
crossref_primary_10_3389_fendo_2023_1063882
crossref_primary_10_1097_MD_0000000000011293
crossref_primary_10_1016_j_numecd_2022_12_017
crossref_primary_10_1016_j_orcp_2020_09_008
crossref_primary_10_1016_j_phrs_2018_01_009
crossref_primary_10_3390_jcm7120528
crossref_primary_10_3904_kjim_2017_343
crossref_primary_10_1016_j_dld_2017_12_014
crossref_primary_10_1161_ATVBAHA_119_313154
crossref_primary_10_1038_s41598_018_29139_6
crossref_primary_10_1111_jgh_15364
crossref_primary_10_1017_S0007114519000345
crossref_primary_10_1111_obr_13054
crossref_primary_10_1038_s41598_022_23324_4
crossref_primary_10_1097_RCT_0000000000001193
crossref_primary_10_18632_oncotarget_24677
crossref_primary_10_2459_JCM_0000000000001433
crossref_primary_10_2337_db21_0674
crossref_primary_10_1016_j_clnesp_2019_04_010
crossref_primary_10_1186_s13098_019_0503_1
crossref_primary_10_1016_j_jns_2019_07_016
crossref_primary_10_17116_profmed20202303169
crossref_primary_10_3390_nu11092200
crossref_primary_10_1002_oby_22294
crossref_primary_10_1080_03630242_2018_1539429
crossref_primary_10_22363_2313_0245_2022_26_4_382_395
crossref_primary_10_1016_j_celrep_2021_108804
crossref_primary_10_1080_21623945_2018_1445889
crossref_primary_10_1590_1517_869220202601187736
crossref_primary_10_1089_met_2023_0223
crossref_primary_10_1002_ana_26775
crossref_primary_10_3390_jcm10040835
crossref_primary_10_1016_j_jdiacomp_2019_03_007
crossref_primary_10_1001_jamanetworkopen_2024_34699
crossref_primary_10_1152_ajpendo_00439_2018
crossref_primary_10_3390_ijms20112707
crossref_primary_10_1186_s12933_019_0907_0
crossref_primary_10_1017_thg_2019_46
crossref_primary_10_1186_s40001_023_01205_4
crossref_primary_10_34071_jmp_2018_6_4
crossref_primary_10_1016_j_ejrad_2024_111545
crossref_primary_10_3389_fpsyt_2021_711835
crossref_primary_10_3390_cancers14215256
crossref_primary_10_1016_j_xcrm_2021_100332
crossref_primary_10_1016_j_jaad_2018_10_081
crossref_primary_10_1080_21623945_2019_1648175
crossref_primary_10_1186_s12889_021_11316_4
crossref_primary_10_3390_nu14153220
crossref_primary_10_3390_nu13051588
crossref_primary_10_1038_s41366_020_00657_6
crossref_primary_10_1111_eci_13693
crossref_primary_10_1080_03007995_2019_1654988
crossref_primary_10_1007_s13679_023_00531_2
crossref_primary_10_3390_arm92060048
crossref_primary_10_3390_nu14010208
crossref_primary_10_1038_s41390_022_01941_z
crossref_primary_10_3889_oamjms_2022_9708
crossref_primary_10_1111_nbu_12537
crossref_primary_10_3389_fcvm_2020_00091
crossref_primary_10_3390_cells8070673
crossref_primary_10_1515_hmbci_2018_0012
crossref_primary_10_1210_endocr_bqaa044
crossref_primary_10_3390_nu16091301
crossref_primary_10_1002_ana_27109
crossref_primary_10_3390_diagnostics14182095
crossref_primary_10_1016_j_numecd_2021_05_012
crossref_primary_10_1038_s41598_019_49162_5
crossref_primary_10_1016_j_molmet_2020_01_001
crossref_primary_10_5712_rbmfc15_42_2605
crossref_primary_10_1016_j_biopha_2020_110889
crossref_primary_10_1016_j_orcp_2021_03_007
crossref_primary_10_1017_S0007114518003392
crossref_primary_10_3389_fphys_2022_946402
crossref_primary_10_3803_EnM_2022_1532
crossref_primary_10_1210_clinem_dgad666
crossref_primary_10_1371_journal_pone_0298662
crossref_primary_10_1038_s41366_021_00767_9
crossref_primary_10_1186_s13098_021_00679_8
Cites_doi 10.1161/CIRCULATIONAHA.106.675355
10.1016/j.cgh.2015.07.024
10.1161/CIR.0b013e318233bc6a
10.2183/pjab.88.454
10.1111/liv.13332
10.1046/j.1467-789x.2000.00008.x
10.1097/MD.0000000000000573
10.1136/gut.2007.147090
10.1038/oby.2009.443
10.1038/oby.2003.64
10.2337/diabetes.52.2.283
10.2337/dc10-0879
10.2337/diabetes.53.8.2087
10.1155/2012/175245
10.2337/dc11-1583
10.1016/j.jcmg.2014.07.017
10.1093/eurheartj/ehl524
10.1210/jc.2011-0615
10.2337/dc08-2280
10.3945/ajcn.110.007153
10.1161/circulationaha.109.192644
10.1371/journal.pone.0027694
10.1038/nri2921
10.1210/jc.2010-1378
10.1161/circulationaha.105.169404
10.2337/dc10-0606
10.1161/CIRCULATIONAHA.114.015000
10.5551/jat.12294
10.1111/j.1467-789X.2009.00623.x
10.4093/dmj.2011.35.6.561
10.1016/j.jacc.2016.06.067
10.1152/physrev.00017.2012
10.1038/oby.2008.292
10.1111/liv.12552
10.1016/j.orcp.2010.07.001
10.1002/oby.20135
10.2337/dc10-1364
10.1001/jama.288.21.2709
10.1038/nature05488
ContentType Journal Article
Copyright The Author(s) 2017
2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2017
– notice: 2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/s41598-017-09723-y
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 8
ExternalDocumentID PMC5591218
28887474
10_1038_s41598_017_09723_y
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7XB
8FK
AARCD
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c474t-7c410a7c62dc3a232cabeb2f96d18f64cec0cfd4e5d745b22a6bc17490a9833b3
IEDL.DBID M48
ISSN 2045-2322
IngestDate Thu Aug 21 18:08:31 EDT 2025
Thu Jul 10 21:56:12 EDT 2025
Wed Aug 13 04:44:48 EDT 2025
Mon Jul 21 05:49:20 EDT 2025
Tue Jul 01 02:41:00 EDT 2025
Thu Apr 24 23:03:58 EDT 2025
Fri Feb 21 02:39:56 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-7c410a7c62dc3a232cabeb2f96d18f64cec0cfd4e5d745b22a6bc17490a9833b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-1919-6800
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-017-09723-y
PMID 28887474
PQID 1953983312
PQPubID 2041939
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5591218
proquest_miscellaneous_1937530715
proquest_journals_1953983312
pubmed_primary_28887474
crossref_primary_10_1038_s41598_017_09723_y
crossref_citationtrail_10_1038_s41598_017_09723_y
springer_journals_10_1038_s41598_017_09723_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-09-08
PublicationDateYYYYMMDD 2017-09-08
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-08
  day: 08
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2017
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References McLaughlinTLamendolaCLiuAAbbasiFPreferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivityJ Clin Endocrinol Metab201196E175617601:CAS:528:DC%2BC3MXhsV2nur%2FI10.1210/jc.2011-0615218653613205890
KwakM-SKimDChungGEKimWKimJSThe preventive effect of sustained physical activity on incident nonalcoholic fatty liver diseaseLiver International2017379199261:CAS:528:DC%2BC2sXotlSqsLs%3D10.1111/liv.1333227917585
OuchiNParkerJLLugusJJWalshKAdipokines in inflammation and metabolic diseaseNat Rev Immunol20111185971:CAS:528:DC%2BC3MXotlSgsg%3D%3D10.1038/nri2921212529893518031
NakaoYMIntra-abdominal fat area is a predictor for new onset of individual components of metabolic syndrome: MEtabolic syndRome and abdominaL ObesiTy (MERLOT study)Proceedings of the Japan Academy, Series B2012884544612012PJAB...88..454N10.2183/pjab.88.454
World Health Organization. Global status report on noncommunicable diseases 2014. (Geneva, 2014).
TrayhurnPHypoxia and Adipose Tissue Function and Dysfunction in ObesityPhysiological Reviews2013931211:CAS:528:DC%2BC3sXhvFKnsro%3D10.1152/physrev.00017.201223303904
AbrahamTMPedleyAMassaroJMHoffmannUFoxCSAssociation between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factorsCirculation2015132163916471:CAS:528:DC%2BC2MXhslGltrnF10.1161/CIRCULATIONAHA.114.015000262946604779497
KimDBody Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology201614132138.e13410.1016/j.cgh.2015.07.02426226099
World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment (2000).
KoskaJDistribution of Subcutaneous Fat Predicts Insulin Action in Obesity in Sex-specific MannerObesity200816200320091:CAS:528:DC%2BD1cXhtVGgtLvI10.1038/oby.2008.292185511272692524
NeelandIJAssociations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adultsObesity201321E439E4471:CAS:528:DC%2BC3sXhsFGgtLvJ236870993751977
MozumdarALiguoriGPersistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006Diabetes care20113421621910.2337/dc10-087920889854
ChungGEVisceral Adipose Tissue Area as an Independent Risk Factor for Elevated Liver Enzyme in Nonalcoholic Fatty Liver DiseaseMedicine2015941:CAS:528:DC%2BC2MXktVemsLg%3D10.1097/MD.0000000000000573257384754553965
OhSWObesity and Metabolic Syndrome in KoreaDiabetes Metab J20113556156610.4093/dmj.2011.35.6.561222478963253964
AlbertiKGMMHarmonizing the Metabolic SyndromeA Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity2009120164016451:CAS:528:DC%2BD1MXht1OrtrrK
LakkaHMThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged menJAMA20022882709271610.1001/jama.288.21.270912460094
DeschênesDCouturePDupontPTchernofASubdivision of the Subcutaneous Adipose Tissue Compartment and Lipid-Lipoprotein Levels in WomenObesity research20031146947610.1038/oby.2003.6412634447
GrundySMDiagnosis and Management of the Metabolic SyndromeAn American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement200511227352752
SongSWRelationships between visceral adipose tissue measurement site and the metabolic syndrome in the Korean populationObes Res Clin Pract20104e24734210.1016/j.orcp.2010.07.00124345690
OkaRImpact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged JapaneseJ Atheroscler Thromb2012198148221:CAS:528:DC%2BC3sXitFartg%3D%3D10.5551/jat.1229422813532
LeeJJPedleyAHoffmannUMassaroJMFoxCSAssociation of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk FactorsJournal of the American College of Cardiology2016681509152110.1016/j.jacc.2016.06.06727687192
WildmanRPSubcutaneous adipose tissue in relation to subclinical atherosclerosis and cardiometabolic risk factors in midlife womenThe American journal of clinical nutrition2011937197261:CAS:528:DC%2BC3MXjvFahurY%3D10.3945/ajcn.110.007153213460893057544
WangJThe metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic FinnsEuropean Heart Journal20072885786410.1093/eurheartj/ehl52417303589
GolanRAbdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetesDiabetes care2012356406471:CAS:528:DC%2BC38XltFGksLg%3D10.2337/dc11-1583223446123322677
YimJYSagittal Abdominal Diameter Is a Strong Anthropometric Measure of Visceral Adipose Tissue in the Asian General PopulationDiabetes care2010332665267010.2337/dc10-0606208439762992209
DespresJ-PLemieuxIAbdominal obesity and metabolic syndromeNature20064448818872006Natur.444..881D1:CAS:528:DC%2BD28XhtlShtrzF10.1038/nature0548817167477
VirtanenKADifferential Effects of Rosiglitazone and Metformin on Adipose Tissue Distribution and Glucose Uptake in Type 2 Diabetic SubjectsDiabetes2003522832901:CAS:528:DC%2BD3sXhtFagu7c%3D10.2337/diabetes.52.2.28312540598
PorterSAAbdominal subcutaneous adipose tissue: a protective fat depot?Diabetes care2009321068107510.2337/dc08-2280192440872681034
CornierM-AAssessing AdiposityA Scientific Statement From the American Heart Association201112419962019
IbrahimMMSubcutaneous and visceral adipose tissue: structural and functional differencesObesity Reviews201011111810.1111/j.1467-789X.2009.00623.x19656312
BoselloOZamboniMVisceral obesity and metabolic syndromeObesity Reviews2000147561:STN:280:DC%2BD38znsVCqsg%3D%3D10.1046/j.1467-789x.2000.00008.x12119645
Di ChiaraTArganoCCorraoSScaglioneRLicataGHypoadiponectinemia: A Link between Visceral Obesity and Metabolic SyndromeJournal of Nutrition and Metabolism2012201210.1155/2012/17524522013516
ShahRVVisceral adiposity and the risk of metabolic syndrome across body mass index: the MESA StudyJACC Cardiovasc Imaging201471221123510.1016/j.jcmg.2014.07.017254405914268163
KwakM-SRole of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistanceLiver International20153594495210.1111/liv.1255224684289
KimSDistribution of Abdominal Visceral and Subcutaneous Adipose Tissue and Metabolic Syndrome in a Korean PopulationDiabetes care20113450450610.2337/dc10-1364212282453024376
SamarasKBotelhoNKChisholmDJLordRVSubcutaneous and Visceral Adipose Tissue Gene Expression of Serum Adipokines That Predict Type 2 DiabetesObesity2010188848891:CAS:528:DC%2BC3cXlt1ahsbY%3D10.1038/oby.2009.44320019678
FoxCSAbdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart StudyCirculation2007116394810.1161/CIRCULATIONAHA.106.67535517576866
CarrDBIntra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic SyndromeDiabetes200453208720941:CAS:528:DC%2BD2cXmtFGqtrk%3D10.2337/diabetes.53.8.208715277390
LiuJImpact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart StudyJ Clin Endocrinol Metab201095541954261:CAS:528:DC%2BC3cXhs1arsLnJ10.1210/jc.2010-1378208439522999970
KangSMAndroid fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly peoplePloS one201162011PLoSO...627694K1:CAS:528:DC%2BC3MXhsF2isLvP10.1371/journal.pone.0027694220966133214067
ChungSJMetabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-upsGut200857136013651:STN:280:DC%2BD1crpvF2rug%3D%3D10.1136/gut.2007.14709018441006
J Wang (9723_CR4) 2007; 28
K Samaras (9723_CR29) 2010; 18
KA Virtanen (9723_CR31) 2003; 52
O Bosello (9723_CR30) 2000; 1
M-A Cornier (9723_CR26) 2011; 124
YM Nakao (9723_CR16) 2012; 88
TM Abraham (9723_CR21) 2015; 132
SW Song (9723_CR20) 2010; 4
JJ Lee (9723_CR22) 2016; 68
S Kim (9723_CR19) 2011; 34
SW Oh (9723_CR5) 2011; 35
DB Carr (9723_CR25) 2004; 53
GE Chung (9723_CR36) 2015; 94
CS Fox (9723_CR12) 2007; 116
A Mozumdar (9723_CR6) 2011; 34
D Kim (9723_CR35) 2016; 14
SM Kang (9723_CR24) 2011; 6
SA Porter (9723_CR13) 2009; 32
RV Shah (9723_CR23) 2014; 7
J-P Despres (9723_CR17) 2006; 444
M-S Kwak (9723_CR38) 2015; 35
9723_CR1
R Oka (9723_CR10) 2012; 19
IJ Neeland (9723_CR9) 2013; 21
MM Ibrahim (9723_CR18) 2010; 11
J Koska (9723_CR34) 2008; 16
SM Grundy (9723_CR40) 2005; 112
RP Wildman (9723_CR15) 2011; 93
M-S Kwak (9723_CR37) 2017; 37
J Liu (9723_CR14) 2010; 95
P Trayhurn (9723_CR27) 2013; 93
R Golan (9723_CR32) 2012; 35
D Deschênes (9723_CR33) 2003; 11
HM Lakka (9723_CR3) 2002; 288
T McLaughlin (9723_CR11) 2011; 96
SJ Chung (9723_CR39) 2008; 57
T Di Chiara (9723_CR28) 2012; 2012
9723_CR41
KGMM Alberti (9723_CR7) 2009; 120
N Ouchi (9723_CR2) 2011; 11
JY Yim (9723_CR8) 2010; 33
References_xml – reference: CornierM-AAssessing AdiposityA Scientific Statement From the American Heart Association201112419962019
– reference: VirtanenKADifferential Effects of Rosiglitazone and Metformin on Adipose Tissue Distribution and Glucose Uptake in Type 2 Diabetic SubjectsDiabetes2003522832901:CAS:528:DC%2BD3sXhtFagu7c%3D10.2337/diabetes.52.2.28312540598
– reference: ChungSJMetabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-upsGut200857136013651:STN:280:DC%2BD1crpvF2rug%3D%3D10.1136/gut.2007.14709018441006
– reference: WangJThe metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic FinnsEuropean Heart Journal20072885786410.1093/eurheartj/ehl52417303589
– reference: GolanRAbdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetesDiabetes care2012356406471:CAS:528:DC%2BC38XltFGksLg%3D10.2337/dc11-1583223446123322677
– reference: BoselloOZamboniMVisceral obesity and metabolic syndromeObesity Reviews2000147561:STN:280:DC%2BD38znsVCqsg%3D%3D10.1046/j.1467-789x.2000.00008.x12119645
– reference: ShahRVVisceral adiposity and the risk of metabolic syndrome across body mass index: the MESA StudyJACC Cardiovasc Imaging201471221123510.1016/j.jcmg.2014.07.017254405914268163
– reference: OhSWObesity and Metabolic Syndrome in KoreaDiabetes Metab J20113556156610.4093/dmj.2011.35.6.561222478963253964
– reference: OkaRImpact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged JapaneseJ Atheroscler Thromb2012198148221:CAS:528:DC%2BC3sXitFartg%3D%3D10.5551/jat.1229422813532
– reference: KimSDistribution of Abdominal Visceral and Subcutaneous Adipose Tissue and Metabolic Syndrome in a Korean PopulationDiabetes care20113450450610.2337/dc10-1364212282453024376
– reference: DespresJ-PLemieuxIAbdominal obesity and metabolic syndromeNature20064448818872006Natur.444..881D1:CAS:528:DC%2BD28XhtlShtrzF10.1038/nature0548817167477
– reference: Di ChiaraTArganoCCorraoSScaglioneRLicataGHypoadiponectinemia: A Link between Visceral Obesity and Metabolic SyndromeJournal of Nutrition and Metabolism2012201210.1155/2012/17524522013516
– reference: OuchiNParkerJLLugusJJWalshKAdipokines in inflammation and metabolic diseaseNat Rev Immunol20111185971:CAS:528:DC%2BC3MXotlSgsg%3D%3D10.1038/nri2921212529893518031
– reference: SongSWRelationships between visceral adipose tissue measurement site and the metabolic syndrome in the Korean populationObes Res Clin Pract20104e24734210.1016/j.orcp.2010.07.00124345690
– reference: ChungGEVisceral Adipose Tissue Area as an Independent Risk Factor for Elevated Liver Enzyme in Nonalcoholic Fatty Liver DiseaseMedicine2015941:CAS:528:DC%2BC2MXktVemsLg%3D10.1097/MD.0000000000000573257384754553965
– reference: World Health Organization. Global status report on noncommunicable diseases 2014. (Geneva, 2014).
– reference: NakaoYMIntra-abdominal fat area is a predictor for new onset of individual components of metabolic syndrome: MEtabolic syndRome and abdominaL ObesiTy (MERLOT study)Proceedings of the Japan Academy, Series B2012884544612012PJAB...88..454N10.2183/pjab.88.454
– reference: KoskaJDistribution of Subcutaneous Fat Predicts Insulin Action in Obesity in Sex-specific MannerObesity200816200320091:CAS:528:DC%2BD1cXhtVGgtLvI10.1038/oby.2008.292185511272692524
– reference: KangSMAndroid fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly peoplePloS one201162011PLoSO...627694K1:CAS:528:DC%2BC3MXhsF2isLvP10.1371/journal.pone.0027694220966133214067
– reference: World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment (2000).
– reference: NeelandIJAssociations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adultsObesity201321E439E4471:CAS:528:DC%2BC3sXhsFGgtLvJ236870993751977
– reference: LeeJJPedleyAHoffmannUMassaroJMFoxCSAssociation of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk FactorsJournal of the American College of Cardiology2016681509152110.1016/j.jacc.2016.06.06727687192
– reference: KwakM-SKimDChungGEKimWKimJSThe preventive effect of sustained physical activity on incident nonalcoholic fatty liver diseaseLiver International2017379199261:CAS:528:DC%2BC2sXotlSqsLs%3D10.1111/liv.1333227917585
– reference: WildmanRPSubcutaneous adipose tissue in relation to subclinical atherosclerosis and cardiometabolic risk factors in midlife womenThe American journal of clinical nutrition2011937197261:CAS:528:DC%2BC3MXjvFahurY%3D10.3945/ajcn.110.007153213460893057544
– reference: SamarasKBotelhoNKChisholmDJLordRVSubcutaneous and Visceral Adipose Tissue Gene Expression of Serum Adipokines That Predict Type 2 DiabetesObesity2010188848891:CAS:528:DC%2BC3cXlt1ahsbY%3D10.1038/oby.2009.44320019678
– reference: AlbertiKGMMHarmonizing the Metabolic SyndromeA Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity2009120164016451:CAS:528:DC%2BD1MXht1OrtrrK
– reference: AbrahamTMPedleyAMassaroJMHoffmannUFoxCSAssociation between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factorsCirculation2015132163916471:CAS:528:DC%2BC2MXhslGltrnF10.1161/CIRCULATIONAHA.114.015000262946604779497
– reference: GrundySMDiagnosis and Management of the Metabolic SyndromeAn American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement200511227352752
– reference: MozumdarALiguoriGPersistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006Diabetes care20113421621910.2337/dc10-087920889854
– reference: LiuJImpact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart StudyJ Clin Endocrinol Metab201095541954261:CAS:528:DC%2BC3cXhs1arsLnJ10.1210/jc.2010-1378208439522999970
– reference: KwakM-SRole of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistanceLiver International20153594495210.1111/liv.1255224684289
– reference: LakkaHMThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged menJAMA20022882709271610.1001/jama.288.21.270912460094
– reference: FoxCSAbdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart StudyCirculation2007116394810.1161/CIRCULATIONAHA.106.67535517576866
– reference: McLaughlinTLamendolaCLiuAAbbasiFPreferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivityJ Clin Endocrinol Metab201196E175617601:CAS:528:DC%2BC3MXhsV2nur%2FI10.1210/jc.2011-0615218653613205890
– reference: PorterSAAbdominal subcutaneous adipose tissue: a protective fat depot?Diabetes care2009321068107510.2337/dc08-2280192440872681034
– reference: IbrahimMMSubcutaneous and visceral adipose tissue: structural and functional differencesObesity Reviews201011111810.1111/j.1467-789X.2009.00623.x19656312
– reference: CarrDBIntra-Abdominal Fat Is a Major Determinant of the National Cholesterol Education Program Adult Treatment Panel III Criteria for the Metabolic SyndromeDiabetes200453208720941:CAS:528:DC%2BD2cXmtFGqtrk%3D10.2337/diabetes.53.8.208715277390
– reference: TrayhurnPHypoxia and Adipose Tissue Function and Dysfunction in ObesityPhysiological Reviews2013931211:CAS:528:DC%2BC3sXhvFKnsro%3D10.1152/physrev.00017.201223303904
– reference: DeschênesDCouturePDupontPTchernofASubdivision of the Subcutaneous Adipose Tissue Compartment and Lipid-Lipoprotein Levels in WomenObesity research20031146947610.1038/oby.2003.6412634447
– reference: YimJYSagittal Abdominal Diameter Is a Strong Anthropometric Measure of Visceral Adipose Tissue in the Asian General PopulationDiabetes care2010332665267010.2337/dc10-0606208439762992209
– reference: KimDBody Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology201614132138.e13410.1016/j.cgh.2015.07.02426226099
– volume: 116
  start-page: 39
  year: 2007
  ident: 9723_CR12
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.675355
– volume: 14
  start-page: 132
  year: 2016
  ident: 9723_CR35
  publication-title: Clinical Gastroenterology and Hepatology
  doi: 10.1016/j.cgh.2015.07.024
– volume: 124
  start-page: 1996
  year: 2011
  ident: 9723_CR26
  publication-title: A Scientific Statement From the American Heart Association
  doi: 10.1161/CIR.0b013e318233bc6a
– volume: 88
  start-page: 454
  year: 2012
  ident: 9723_CR16
  publication-title: Proceedings of the Japan Academy, Series B
  doi: 10.2183/pjab.88.454
– volume: 37
  start-page: 919
  year: 2017
  ident: 9723_CR37
  publication-title: Liver International
  doi: 10.1111/liv.13332
– volume: 1
  start-page: 47
  year: 2000
  ident: 9723_CR30
  publication-title: Obesity Reviews
  doi: 10.1046/j.1467-789x.2000.00008.x
– volume: 94
  year: 2015
  ident: 9723_CR36
  publication-title: Medicine
  doi: 10.1097/MD.0000000000000573
– ident: 9723_CR41
– volume: 57
  start-page: 1360
  year: 2008
  ident: 9723_CR39
  publication-title: Gut
  doi: 10.1136/gut.2007.147090
– volume: 18
  start-page: 884
  year: 2010
  ident: 9723_CR29
  publication-title: Obesity
  doi: 10.1038/oby.2009.443
– volume: 11
  start-page: 469
  year: 2003
  ident: 9723_CR33
  publication-title: Obesity research
  doi: 10.1038/oby.2003.64
– volume: 52
  start-page: 283
  year: 2003
  ident: 9723_CR31
  publication-title: Diabetes
  doi: 10.2337/diabetes.52.2.283
– volume: 34
  start-page: 216
  year: 2011
  ident: 9723_CR6
  publication-title: Diabetes care
  doi: 10.2337/dc10-0879
– volume: 53
  start-page: 2087
  year: 2004
  ident: 9723_CR25
  publication-title: Diabetes
  doi: 10.2337/diabetes.53.8.2087
– volume: 2012
  year: 2012
  ident: 9723_CR28
  publication-title: Journal of Nutrition and Metabolism
  doi: 10.1155/2012/175245
– volume: 35
  start-page: 640
  year: 2012
  ident: 9723_CR32
  publication-title: Diabetes care
  doi: 10.2337/dc11-1583
– volume: 7
  start-page: 1221
  year: 2014
  ident: 9723_CR23
  publication-title: JACC Cardiovasc Imaging
  doi: 10.1016/j.jcmg.2014.07.017
– volume: 28
  start-page: 857
  year: 2007
  ident: 9723_CR4
  publication-title: European Heart Journal
  doi: 10.1093/eurheartj/ehl524
– volume: 96
  start-page: E1756
  year: 2011
  ident: 9723_CR11
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-0615
– volume: 32
  start-page: 1068
  year: 2009
  ident: 9723_CR13
  publication-title: Diabetes care
  doi: 10.2337/dc08-2280
– volume: 93
  start-page: 719
  year: 2011
  ident: 9723_CR15
  publication-title: The American journal of clinical nutrition
  doi: 10.3945/ajcn.110.007153
– volume: 120
  start-page: 1640
  year: 2009
  ident: 9723_CR7
  publication-title: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and Interna
  doi: 10.1161/circulationaha.109.192644
– volume: 6
  year: 2011
  ident: 9723_CR24
  publication-title: PloS one
  doi: 10.1371/journal.pone.0027694
– volume: 11
  start-page: 85
  year: 2011
  ident: 9723_CR2
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2921
– volume: 95
  start-page: 5419
  year: 2010
  ident: 9723_CR14
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2010-1378
– volume: 112
  start-page: 2735
  year: 2005
  ident: 9723_CR40
  publication-title: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
  doi: 10.1161/circulationaha.105.169404
– volume: 33
  start-page: 2665
  year: 2010
  ident: 9723_CR8
  publication-title: Diabetes care
  doi: 10.2337/dc10-0606
– volume: 132
  start-page: 1639
  year: 2015
  ident: 9723_CR21
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.114.015000
– volume: 19
  start-page: 814
  year: 2012
  ident: 9723_CR10
  publication-title: J Atheroscler Thromb
  doi: 10.5551/jat.12294
– volume: 11
  start-page: 11
  year: 2010
  ident: 9723_CR18
  publication-title: Obesity Reviews
  doi: 10.1111/j.1467-789X.2009.00623.x
– volume: 35
  start-page: 561
  year: 2011
  ident: 9723_CR5
  publication-title: Diabetes Metab J
  doi: 10.4093/dmj.2011.35.6.561
– volume: 68
  start-page: 1509
  year: 2016
  ident: 9723_CR22
  publication-title: Journal of the American College of Cardiology
  doi: 10.1016/j.jacc.2016.06.067
– volume: 93
  start-page: 1
  year: 2013
  ident: 9723_CR27
  publication-title: Physiological Reviews
  doi: 10.1152/physrev.00017.2012
– volume: 16
  start-page: 2003
  year: 2008
  ident: 9723_CR34
  publication-title: Obesity
  doi: 10.1038/oby.2008.292
– volume: 35
  start-page: 944
  year: 2015
  ident: 9723_CR38
  publication-title: Liver International
  doi: 10.1111/liv.12552
– volume: 4
  start-page: e247
  year: 2010
  ident: 9723_CR20
  publication-title: Obes Res Clin Pract
  doi: 10.1016/j.orcp.2010.07.001
– volume: 21
  start-page: E439
  year: 2013
  ident: 9723_CR9
  publication-title: Obesity
  doi: 10.1002/oby.20135
– ident: 9723_CR1
– volume: 34
  start-page: 504
  year: 2011
  ident: 9723_CR19
  publication-title: Diabetes care
  doi: 10.2337/dc10-1364
– volume: 288
  start-page: 2709
  year: 2002
  ident: 9723_CR3
  publication-title: JAMA
  doi: 10.1001/jama.288.21.2709
– volume: 444
  start-page: 881
  year: 2006
  ident: 9723_CR17
  publication-title: Nature
  doi: 10.1038/nature05488
SSID ssj0000529419
Score 2.5530646
Snippet The effect of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) area on metabolic syndrome (MS) has been debated. We aimed to evaluate the...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 10955
SubjectTerms 692/163/2743/2037
692/163/2743/393
Adipose tissue
Adult
Blood Glucose - analysis
Blood Pressure
Body fat
Body Fat Distribution
Cohort analysis
Female
Humanities and Social Sciences
Humans
Hypertension
Intra-Abdominal Fat - anatomy & histology
Male
Metabolic disorders
Metabolic syndrome
Metabolic Syndrome - epidemiology
Middle Aged
multidisciplinary
Science
Science (multidisciplinary)
Subcutaneous Fat - anatomy & histology
Sugar
Triglycerides
Triglycerides - blood
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB4VKiQuFX0AobRyJW5tRBI7ccylorQrVEEPbZH2RBQ_ol2BEspmD_n3nUm8abeoXHKxo8Tj8Xge9vcBHAm6vigxLKnyqAqFwIfSqQ1TqmLhdq8iRwn9y2_Z-ZX4Ok2nPuG28McqVzaxN9S2MZQjP6Zyj8o5j5OPd79CYo2i6qqn0NiApwRdRke65FSOORaqYolY-bsyEc-PF7hf0Z0yNM2EW8PDbn0_euBkPjwr-U_BtN-HJjvwzDuQ7HSY8efwxNUvYGuglOxewvWnxnZsUrbsM0HiejYrVtaWoavHvs8XN6ypGJoFYhNt2aVrUQ1u54b98NgFJ-yUXTREY7S0RJnFzpoZ-uiMThx2r-Bq8uXn2XnoORRCI6RoQ2lEHJXSZIk1vET3yZQag-lKZTbOq0wYZyJTWeFSK0Wqk6TMtMEoRUUlSVvzXdism9rtA8u4weAiMVJlTihpdaR1JnDZEoKVU1UA8UqShfEA48RzcVv0hW6eF4P0C5R-0Uu_6AJ4P75zN8BrPNr7cDVBhV9qi-KPYgTwbmzGRUKVj7J2zZL6cAzL0JtKA9gb5nP8XJKjnUVZBSDXZnrsQADc6y31fNYDcWM0FqOLFMCHlU789Vv_HcXB46N4DdvJoJ9hlB_CZnu_dG_Q8Wn12167fwMiRgA7
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NT90wDLeACYnLBNtgBTYFiRur1jZp2uzGHntCE3AYIHGiaj4qnkDttNd36H-P3S_xxkDapZcmamo7sR3bPwMcCipfTNAtKdKg8IXAh9Kx9WOKYqG6V4GjC_3zC3l6LX7exDcrEA21MG3Sfgtp2R7TQ3bY1zkqGioGwzOVAGe436zCG4JuJ6meyMl4r0KRKxGqvj4m4Ok_pi7roGeG5fP8yL-CpK3umW7C295oZMfdMrdgxZXvYL1rI9m8h9vvlW3YNK_ZCcHg9h2sWF5ahuYd-zWb37OqYHgUUAfRmp27Gln_MDPssscr-MaO2VlFrYsWltpksUl1h3Y5oyzD5gNcT39cTU79vm-Cb0Qiaj8xIgzyxMjIGp6jyWRyjQ50oaQN00IK40xgCitcbBMR6yjKpTbomaggVynnmm_DWlmV7iMwyQ06FJFJlHRCJVYHWkuBW5VQq5wqPAgHSmamBxWn3hYPWRvc5mnWUT9D6mct9bPGg6Nxzu8OUuPV0fsDg7J-e80ziv3RUsPIg4PxNW4MinbkpasWNIajK4YWVOzBTsfP8XMR-v3oRwkPkiVOjwMIdHv5TTm7a8G30QML0Szy4MsgE0-W9eJf7P7f8D3YiDp59YN0H9bqPwv3CY2fWn9upf0Rr9n-ig
  priority: 102
  providerName: Springer Nature
Title Body Fat Distribution and the Risk of Incident Metabolic Syndrome: A Longitudinal Cohort Study
URI https://link.springer.com/article/10.1038/s41598-017-09723-y
https://www.ncbi.nlm.nih.gov/pubmed/28887474
https://www.proquest.com/docview/1953983312
https://www.proquest.com/docview/1937530715
https://pubmed.ncbi.nlm.nih.gov/PMC5591218
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ra9RAEB_6QPBLqe_YeqzgN40mm002EUSuZ49yeEVaD-6TIfsIPTyS2suB-e-dyePwbBW_JJBsks3szM5MJvv7AbwStHxRYlqSx17uCoGbRIXGDamKhe4-8Sx90J-eR2czMZmH8x3o6Y46Aa7uTO2IT2p2s3z780f9EQ3-Q7tkPH63QidEC8VwviUwmsCtd2EfPZMkQ5124X6L9c0T0XB9EAi7i8EE79bR3H2bbV91KwC9_R_lH8XUxkeND-GgCy7ZsNWGB7Bji4dwr6WbrB_Bt5PS1GycVewTweV2TFcsKwzDMJBdLFbfWZkznDKIabRiU1uhiiwXml12uAbv2ZB9LoniaG2ITouNyisUHaO_EevHMBuffh2duR2_gquFFJUrtfC9TOqIGx1kKA2dKUy08yQyfpxHQlvt6dwIGxopQsV5FimNGUziZUkcBCp4AntFWdhnwKJAY-LBtUwiKxJplKdUJNCkCd3KJrkDfi_JVHfg48SBsUybIngQp630U5R-2kg_rR14vbnmuoXe-Gfr436A0l6LUqoRUld97sDLzWk0IKqKZIUt19QmwJQNI63QgafteG4ex2Ocg1FWDsitkd40IHDu7TPF4qoB6cZMzcfwyYE3vU781q2_vsXz_-jmEdznrZK6XnwMe9XN2r7AyKhSA9iVczmA_eFwcjnB_cnp-ZcLPDqKRoPma8OgMYhfnzANZw
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrRBcUHkHChgJThA1sZ0XUoX6Wm3p7gqVVuqpIbEddUWVFDYrlD_V39iZvGCp6K2XXOzE8Xg8D49nPoB3ktIXA3RLstDJbCnxEaWetj2KYqG6jxxDB_qTqT86ll9OvJMVuOxyYehaZScTa0GtC0Vn5BsU7olCIVz--eKnTahRFF3tIDQatjgw1W902eab-7u4vu85H-4d7YzsFlXAVjKQpR0o6TpJoHyulUjQoFBJiu5lFvnaDTNfKqMclWlpPB1IL-U88VOFdnvkJDR-KvC7d2BVCnRlBrC6vTf9etif6lDcTLpRm53jiHBjjhqSsthQGVClHGFXyxrwmll7_XbmPyHaWvMN1-BBa7KyrYbHHsKKyR_B3QbEsnoMp9uFrtgwKdkuFeFt8bNYkmuGxiU7nM1_sCJjKIgIv7RkE1Mi453PFPvWVkv4xLbYuCDgpIUmkC62U5yhV8DojmP1BI5vhb5PYZAXuXkOzBcK3Rmugsg3Mgp06qSpL1FQUM0sE2UWuB0lY9WWNCdkjfO4Dq2LMG6oHyP145r6cWXBh_6di6agx42917sFitvNPY__sKIFb_tm3JYUa0lyUyyoj0BHEO03z4JnzXr2w_EQJTvSyoJgaaX7DlTye7kln53Vpb_R_3PRKLPgY8cTf_3Wf2fx4uZZvIF7o6PJOB7vTw9ewn3e8KrthOswKH8tzCs0u8r0dcvrDL7f9va6AtUCP5w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIhCXqrzalAJGghNEm8ROnFRCqHRZtfQhBFTaEyF-RF1RJYXNCuWv8euYyQuWit56ycVOYo_n6bHnA3gu6PqixLAkj73cFQIfiQqNG1IWC8194lna0D8-ifZPxftpOF2BX_1dGDpW2evERlGbUtMe-YjSPUnMuR-M8u5YxIfx5M3Fd5cQpCjT2sNptCxyaOufGL7NXx-Mca1fBMHk3ee9fbdDGHC1kKJypRa-l0kdBUbzDJ0LnSkMNfMkMn6cR0Jb7encCBsaKUIVBFmkNPrwiZfRWBTH796Am5KHPsmYnMphf4cyaMJPuns6Ho9Hc7SVdJ8NzQLVzOFuvWwLLzm4l89p_pOsbWzgZB3WOueV7bbcdhdWbHEPbrVwlvV9-PK2NDWbZBUbUzneDkmLZYVh6Gayj7P5N1bmDFUSIZlW7NhWyILnM80-dXUTdtguOyoJQmlhCK6L7ZVnGB8wOu1YP4DTa6HuQ1gtysJuAou4xsAm0DKJrEikUZ5SkUCVQdWzbJI74PeUTHVX3JwwNs7TJsnO47SlforUTxvqp7UDL4d3LtrSHlf23u4XKO3EfJ7-YUoHng3NKKCUdckKWy6oD8eQED250IGNdj2H3wUx6niklQNyaaWHDlT8e7mlmJ01RcAxEvTRPXPgVc8Tfw3rv7PYunoWT-E2ClV6dHBy-AjuBC2rul68DavVj4V9jP5XpZ40jM7g63VL1m8nOkJs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Body+Fat+Distribution+and+the+Risk+of+Incident+Metabolic+Syndrome%3A+A+Longitudinal+Cohort+Study&rft.jtitle=Scientific+reports&rft.au=Kwon%2C+Hyuktae&rft.au=Kim%2C+Donghee&rft.au=Kim%2C+Joo+Sung&rft.date=2017-09-08&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=7&rft.issue=1&rft.spage=10955&rft_id=info:doi/10.1038%2Fs41598-017-09723-y&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon